Mad Money Lightning Round

Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock

Jim Cramer: Palantir Is A 'Winner,' Recommends Selling This Tech Stock

Jim Cramer: This Industrial Stock Is 'Super Strong Buy, A Lifetime Super Strong Buy'

Jim Cramer: Palantir Is A 'Winner,' Recommends Selling This Tech Stock

Jim Cramer: This Industrial Stock Is 'Super Strong Buy, A Lifetime Super Strong Buy'

Jim Cramer Recommends Deckers Outdoor, Realty Income: 'Get A Good Basis'

Jim Cramer Calls This Stock A 'Meme Stock,' Recommends Buying Accenture

Jim Cramer Recommends Deckers Outdoor, Realty Income: 'Get A Good Basis'

Jim Cramer Calls This Stock A 'Meme Stock,' Recommends Buying Accenture

Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock

Jim Cramer: Arthur J. Gallagher Is 'Solid,' This Industrial Company Is 'Fantastic'

Mad Money Lightning Round Recent News

Jim Cramer: Fiserv Is 'One Of The Greatest Fintechs,' Calls This Tech Company A Meme Stock

Fiserv recently completed its acquisition of Payfare Inc. On "Mad Money Lightning Round," Jim Cramer called it "one of the greatest fintechs."

Jim Cramer Likes This Utilities Stock: 'I Think You've Got A Good One'

NextEra Energy posted in-line earnings for the fourth quarter and said it continues to expect adjusted EPS of $3.45-$3.70 for fiscal 2025.

Jim Cramer Says Don't Buy This Financial Stock At This Level: 'Let It Come In'

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended not buying Bitdeer Technologies Group (NASDAQ:BTDR) and going with Bitcoin (CRYPTO:

Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”

Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock

Jim Cramer Says AppFolio Is A 'Good One,' But Summit Therapeutics? 'Can't Go There'

On CNBC's "Mad Money Lightning Round," Jim Cramer said Summit Therapeutics is "obviously just a very big spec."

Jim Cramer: AutoZone Is A 'Great' Stock, Recommends Buying This Energy Stock

AutoZone buys a lot of its own stock, Cramer says. Barclays analyst Matthew McClintock maintains an Overweight rating.

Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business'

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Keysight Technologies calling it a "Terrific business."

Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'

First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on Tuesday, Feb. 25, 2025.

Jim Cramer Recommends Buying 'Fabulous' BlackRock, Calls Coterra Energy The 'Cheapest' Natural Gas Company

Cramer comments on Danaher, Coterra, BlackRock and Digital Realty. As for Grail, "Just great science, but it is parabolic," he adds.

Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? 'Something May Be Wrong Here'

Cramer takes a look at TETRA Technologies, Abbott, Wendy's, Nu Holdings and Casella Waste on the latest edition of "Mad Money."

Jim Cramer Won't 'Get In The Way' Of This Meme Stock, Calls Lam Research 'So Cheap'

"Mad Money" host Jim Cramer recommends buying Lam Research; Keybanc analyst Steve Barger upgraded the stock to Overweight.

Jim Cramer Says This Tech Stock Is Speculative But He Likes It

Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.

Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in.

Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A 'Great Stock'

Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure

Pfizer stock is down more than 7% over the past year. The pharma giant is in talks to extend its collaboration with an AI start-up.

Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower (UPDATED)

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Cramer: 'At This Point,' SoundHound AI Rally 'Is A Short Squeeze'

Jim Cramer recommends buying Home Depot (HD) stock after its strong Q3 earnings and outlook boost. Avoid Hafnia (HAFN), but consider Cleveland-Cliffs (CLF).

Jim Cramer Says Lazard Is 'Really Inexpensive,' Recommends Buying This Tech Stock

Jim Cramer Says Under Armour Is A 'Great Spec,' Recommends Buying This Big Bank Stock

Cramer said Under Armour is a "great spec." However, he recommended being careful. On Dec. 12, Under Armor reiterated its 2025 guidance.

Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock

Jim Cramer likes Walmart (WMT). Walmart provides body cameras to employees in a pilot program. Cramer says Royalty Pharma (RPRX) is a disappointing stock.

Jim Cramer Says This CEO 'Built An Amazing Company,' Recommends Buying Netflix

When asked about Advanced Micro Devices, Cramer asks: "But can we just remember Lisa Su has built an amazing company?"

Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them

Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and Archer Aviation.

;